Category Archives: R&D

Tufts Pegs Drug Development Cost at $2.6 billion – MSF Cries Foul

A cool $2.6 billion is the going rate to develop and gain market approval for a drug, according to the recent study by the Tufts Center for the Study of Drug Development (CSDD).
Posted in R&D | Tagged , , | Leave a comment

Do Oncology Trials Need PR?

Only 3% to 5% of cancer patients participate in clinical trials. Although oncology projects account for almost 31% of global projects, it remains the most difficult therapeutic area in which to conduct clinical trials.  Why, and what can be done to improve patient recruitment?
Posted in R&D | Tagged , | Leave a comment

Top 10 Medical Innovations for 2015

The Cleveland Clinic once again ended its Medical Innovation Summit with a list of 10 advances voted most likely to have a major impact on improving patient care in 2015.
Also posted in Events | Tagged , | Leave a comment

We Need to Rock the Boat to Make Research Soar

By Wayne Kubick, Applied Clinical Trials. We hear it all the time these days: research processes have to undergo transformative changes in order for research organizations to thrive—or even survive. Controlled clinical trials take too long and cost too much. Regulatory review is blocking innovation. Research data must be shared transparently, drug manufacturers need to […]
Also posted in Guest Blog, Op-Ed, Strategy | Tagged , | Leave a comment

NHL Treatment Market Boom Will Be Hindered in EU

The global non-hodgkin lymphoma (NHL) treatment market will increase in value from $5.6 billion in 2013 to $9.2 billion by 2020, according to GBI Research.
Also posted in Europe, Strategy | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta